Click here to see a list of our past events.
Please mark your calendars for this year’s BioInnovate Program Series celebrating life science innovators from Weill Cornell Medicine as well as startup representatives from Cornell University and Cornell Tech.
As AI, new modalities, and cell therapies expand the frontier of drug discovery, what does it take to build the chain of evidence investors and industry partners need to back a novel target? Join our upcoming panel to find out.
You’re invited to the Future of Care Conference 2026. This year's theme "One Size Fits None" captures a new vision for healthcare: medicine designed around the individual, not the average.
Together, we will explore how emerging technologies, artificial intelligence, and innovative care models are redefining the future of personalized medicine. Our conference will bring together an interdisciplinary community of students, clinicians, researchers, entrepreneurs, and industry leaders to share ideas and showcase innovations that are transforming patient care. Throughout the day, attendees will engage with inspiring speakers and thought-provoking conversations centered around advancing more precise, patient-centered healthcare.
Learn more and RSVP at futureofcare.nyc.
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Shannon Collins and program alum Paola Calderon will be in attendance to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.
Participate in a free, month-long I-Corps Regional Course to receive expert guidance as you evaluate the market potential of your deep technology innovation. You’ll gain a deeper understanding of your field and learn valuable professional skills in the process.
In this conference course (May 11 - June 5), a select group of researchers working on oncology technology will "get out of their comfort zone" and talk to customers at the American Society of Clinical Oncology (ASCO) Annual Meeting to identify the best product-market fit. The course begins online and culminates with a trip to Chicago, IL for the 2026 ASCO Annual Meeting. Up to $5,000 (depending on team size) in travel reimbursement funding will be available for accepted teams*.
You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.
Apply here. Applications will be reviewed on a rolling basis. Please contact icorps@cornell.edu for any questions.
Join us for a fireside chat featuring Jennifer Tegan, Managing Director of New York Ventures for Empire State Development. In conversation with a Cornell Entrepreneur in Residence, Jennifer will explore how New York State strengthens its entrepreneurial ecosystem by expanding access to venture capital and supporting high-growth companies.
Whether you’re a founder, investor, or ecosystem builder, this conversation offers valuable insight into how public investment supports startup growth across the state.
Please mark your calendars for this year’s BioInnovate Program Series celebrating life science innovators from Weill Cornell Medicine as well as startup representatives from Cornell University and Cornell Tech.
Join leading investors and industry representatives from organizations including Healthwrx, EpiVax, Fusion Fund, LabyRx, Scion Life Sciences, L.E.K. Consulting, Qiming Venture Partners, and Regeneron for a dynamic series of conversations and events.
This panel of leading life sciences investors and industry representatives will share practical guidance on how academic innovators and spinout teams can strategically engage with potential funders and corporate development partners. The discussion will focus on the intentional steps founders take to secure and maximize high-value interactions with investors and industry, including how to build visibility, credibility, and relationship status.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell business development and licensing professional.
The Apr 21st office hours will be hosted by Eric Bryant, Intellectual Property Officer.
Eric holds a Master of Science in Biomedical Engineering from New York University (NYU), a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution.
His expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
Join our flagship ecosystem-building event, convening investors, industry representatives, entrepreneurs and academic innovators/spinouts.
The 2026 Weill Cornell Medicine BioInnovate Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate. In addition, select startup companies from the Upper East Side ecosystem as well as startups where faculty serve as CMOs and scientific advisors are also in attendance.
Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams.
Join us for a fireside chat with Bakari Akil, Founder and Managing Director of Graves Hall Capital.
In conversation with a Cornell Entrepreneur in Residence, Bakari will share how he built his career by acquiring and growing existing businesses, and what aspiring entrepreneurs should know about this powerful alternative to starting from scratch.
If you're curious about business ownership, this is a conversation you won’t want to miss.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell business development and licensing professional. The Apr 29th office hours will be hosted by Jamie Brisbois, Ph.D., Manager, Business Development and Licensing.
Jamie collaborates with Weill Cornell Medicine innovators to identify, market and license life sciences technologies. Prior to joining the Center for Technology Licensing in 2021, Jamie worked as a consultant with ClearView Healthcare Partners, a boutique health care consulting firm based in Boston. In addition, he served three years as a fellow with Columbia Technology Ventures (CTV), the technology transfer office of Columbia University.
Register here for your 30-minute private session.
